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Acrokeratosis verruciformis of Hopf is a localized dis-
order of keratinization a¡ecting the distal extremities.
Onset is early in life and the disease is inherited in an
autosomal dominant fashion. Although histology of ac-
rokeratosis verruciformis lesions shows no evidence of
dyskeratosis, a possible relationship with Darier’s dis-
ease has long been postulated on the basis of clinical
similarity. ATP2A2 encoding the sarco(endo)plasmic
reticulum Ca2þ ATPase2 pump has been identi¢ed as
the defective gene in Darier’s disease. In this report, we
studied a family a¡ected with acrokeratosis verrucifor-
mis in six generations and identi¢ed a heterozygous
P602L mutation in ATP2A2. This mutation predicts a
nonconservative amino acid substitution in the ATP
binding domain of the molecule. The mutation segre-
gates with the disease phenotype in the family and was
not found in 50 controls. Moreover, functional analysis
of the P602L mutant showed that it has lost its ability
to transport Ca2þ. This result demonstrates loss of
function of the sarco(endo)plasmic reticulum Ca2þ AT-
Pase2 mutant in acrokeratosis verruciformis, thus
providing evidence that acrokeratosis verruciformis
and Darier’s disease are allelic disorders. Key words:
sarco(endo)plasmic reticulum Ca2þ ATPase2. J Invest
Dermatol 120:229 ^232, 2003
A
crokeratosis verruciformis (AKV) was originally
described by Hopf in 1931 (Hopf, 1931). It is a
localized disorder of keratinization, which is inher-
ited as an autosomal dominant trait (Niedelman
and McKusick, 1962). Its onset is early in life
with multiple £at-topped, £esh-colored papules on the hands
and feet, punctate keratoses on the palms and soles, with varying
degrees of nail involvement. The histopathology shows a distinc-
tive pattern of epidermal features with hyperkeratosis, hypergra-
nulosis, and acanthosis together with papillomatosis. These
changes are frequently associated with circumscribed elevations
of the epidermis that are said to resemble church spires
(Waisman, 1960; Schueller, 1972). There are no features of
dyskeratosis or acantholysis, the typical ¢ndings in lesions of
Darier’s disease (DD).
Although initially viewed as distinct entities, AKV and
DD have been considered as related disorders by several
authors, even by Hopf and Darier themselves (Panja, 1977).
A relationship is suggested by the observation that patients
with DD frequently show lesions that are indistinguishable
from AKV, both clinically and histopathologically (Penrod et al,
1960;Waisman, 1960). In one instance, both diseases were seen in
di¡erent members of the same family (Herndon and Wilson,
1966). Moreover, patients with histologic changes of AKV
may later develop the typical histologic features of DD
(Waisman, 1960).
Recently, we identi¢ed ATP2A2 encoding the sarco(endo)-
plasmic reticulum Ca2þ ATPase2 pump (SERCA2) as the defec-
tive gene in DD (Sakuntabhai et al, 1999a). SERCAs are members
of a family of membrane bound ion-motive P-type ATPases,
which are characterized by the obligatory formation of a high en-
ergy phosphorylated intermediate as part of their catalytic cycle.
The active transport of calcium ions from cytosol to sarcoplasmic
or endoplasmic reticulum is brought about by SERCA
at a stoichiometry of two calcium ions translocated for each
ATP hydrolyzed (Inesi et al, 1980). A spectrum of missense, nonse
nse, frameshift, and splicing mutations in ATP2A2 has been de-
scribed in at least 100 families with DD (Jacobsen et al, 1999;
Ruiz-Perez et al, 1999; Sakuntabhai et al, 1999a; 1999b; 2000; Ring-
pfeil et al, 2001;Takahashi et al, 2001;Yang et al, 2001). In addition,
somatic mosaicism for ATP2A2 mutation causes segmental DD
(Sakuntabhai et al, 2000). These results disclosed a key role of this
Ca2þ pump in a signaling pathway regulating cell-to-cell adhe-
sion and di¡erentiation of the epidermis. In this report, we stu-
died a family with AKV and provide functional evidence that
AKV and DD are allelic disorders.
MATERIALS ANDMETHODS
We investigated a 15-year-old male and his family who presented to the
dermatology department in Nottingham with warty lesions on his hands,
wrists, and feet. These had been present since birth. His mother was
similarly a¡ected and questioning revealed a strong family history of the
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disorder spanning six generations (Fig 1), suggestive of autosomal domi-
nant inheritance. The family was of British extraction. On examination,
both the patient and his mother had multiple, £esh-colored, £at-topped
papules, about 2^4 mm in diameter, similar in appearance to plane warts,
on the dorsal aspect of their hands and feet (Fig 2a). A few lesions ex-
tended onto the arms and lower legs. There were multiple yellowish, semi-
translucent punctate keratoses on the palms and soles. The nails were
dystrophic, and clinically similar to those seen in DD with longitudinal
red and white lines, nail fragility, and V-shaped notches at the free edge
(Fig 2b). The rest of the skin was clear, and in particular there was no in-
volvement of seborrhoeic areas.
Clinical information on other a¡ected family members was obtained by
interview.They all had lesions on the backs of their hands except one male
who had palm involvement only (Fig 1). Most had associated nail dystro-
phy. In some, the nails were absent at birth, developing later in infancy.
A biopsy from one of the acral papules from the proband showed strik-
ing changes within the epidermis. There was marked hyperkeratosis,
acanthosis, and papillomatosis with a prominent granular cell layer. There
was no dyskeratosis or cleft formation and no vacuolation of epidermal
cells (Fig 2c). The spiked appearance of the epidermis is typical of acroker-
atosis verruciformis, described by Hopf in 1931.
Mutation analysis Blood samples were obtained from two patients
and una¡ected individuals from the family. Genomic DNAwas extracted
from peripheral blood leukocytes using standard procedures. Polymerase
chain reaction (PCR) ampli¢cation of the 21 exons and £anking
intronic splice sites of ATP2A2 from the proband was performed using
previously published primers and conditions (Sakuntabhai et al, 1999b).
ATP2A2 was screened for mutations by conformation sensitive
gel electrophoresis (CSGE), as described previously (Ganguly et al, 1993).
PCR products showing abnormal electrophoretic mobility were
gel-puri¢ed using QIAquick PCR puri¢cation columns (Qiagen,
Crawley, U.K.) and sequenced directly using the ABI PRISM AmpliTaq
reaction dye terminator cycle-sequencing kit (PE Applied Biosystems,
Warrington, U.K.) and an Applied Biosystems model 377 automated
sequencer. All products were sequenced in the forward and reverse
orientations.
Construction of the ATP2A2 mutant and expression in COS-1
cells The mutation was engineered into ATP2A2 full-length SERCA2b
cDNA clone (kindly provided by Dr. David MacLennan) in the
mammalian expression vector pcDNA3.1 (Invitrogen, Carlsbad, USA)
by site-directed mutagenesis using QuikChangeTM Site-Directed
Mutagenesis Kit (Stratagene, London, U.K.). In order to verify that the
mutation was correct and to ensure that no unwanted mutations had
occurred, sequencing was performed using the previously published
cDNA primers (Sakuntabhai et al, 1999b) on both strands of the mutant
cDNA clone as described above.
The wild-type and the mutant cDNA clones were transiently
overexpressed in the COS-1 cells by the calcium phosphate
coprecipitation method (Sambrook et al, 1989). Isolation of the microsomal
fraction containing the overexpressed Ca2þ ATPase was then carried
out as described previously (Maruyama and MacLennan, 1988).
To determine the localization and the expression level of the mutant
protein in comparison with the wild-type SERCA2b, immunodetection
analysis including immunocytochemistry of intact COS-1 cells and
Western blotting of microsomal protein were performed according
to a standard protocol using a polyclonal anti-SERCA2b antibody
(kindly provided by Dr. FrankWuytack) as described earlier (Verboomen
et al, 1994).
Ca2þ transport assay Ca2þ transport was measured at 371C by the
rapid millipore ¢ltration technique described previously (Vilsen et al,
1989). Brie£y, Ca2þ transport activity was initiated by addition of
microsomes in a reaction mixture containing 20 mM 3-
Morpholinopropanesulfonic acid (pH 6.8), 100 mM KCl, 5 mM MgCl2,
5 mM potassium oxalate, 5 mM ATP, 0.5 mM ethylenediaminetetraacetic
acid, 105 Bq 45Ca2þ per ml, and 0.45 mM CaCl2 to set the free Ca
2þ
concentration at 3.6 mM. The reactions were terminated at times 5, 15, and
30 min by addition of ice-cold stop solution containing 150 mM KCl and
5 mM LaCl3 followed by micropore ¢ltration through 0.45 mM millipore
¢lters and an additional washing with stop solution. The radioactivity
associated with the ¢lters was measured using a Beckman LS 6500
multipurpose scintillation counter (Beckman, Buck, U.K.). The speci¢c
Ca2þ uptake activity (nmoles Ca2þ per mg microsomal protein) of each
experiment was subtracted from background levels determined in the
absence of ATP.
RESULTS
Identi¢cation of a proline to leucine substitution in
ATP2A2 CSGE analysis of ATP2A2 ampli¢ed products from
the proband showed an abnormal electrophoretic mobility in
exon 14 compared with two di¡erent controls (Fig 3a). Direct
sequencing of the PCR product revealed a C to T substitution
at nucleotide position 1805 changing the proline codon 602
to a leucine (P602L) (Fig 3b). This mutation is present at
the heterozygous state and occurs in the ATP binding molecule
Figure1. Family pedigree. A¡ection with AKV shown by solid circle/
square with details of clinical involvement. The proband is marked by an
arrow. A clear autosomal dominant pattern of inheritance is seen.
Figure 2. Clinical features of patients and histopathology of acral
papule from the proband. (a) Dorsal aspect of left foot showing multi-
ple £at-topped papules typical of AKV. (b) Ridging, longitudinal striations,
and splitting of nails similar to that described in one of Hopf’s original
cases. ‘‘The nails all have an opaque, whitish and almost marbled appear-
ance.The normal parts of the nails are only maintained as narrow red long-
itudinal strips. Apart from that, the nails show lamella ¢ssuring and
splintering at the free edge.’’ (c) Section of acral papule showing marked
hyperkeratosis, acanthosis, and papillomatosis, but no dyskeratosis. The ty-
pical ‘‘church spire’’appearance of the epidermis is clearly seen.
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of SERCA2. The P602L mutation was also found in the
other a¡ected individual tested and was absent from un-
a¡ected members, as con¢rmed by typing for mutant-speci¢c
restriction fragments following the creation of a novel DdeI
site (data not shown). This change was not detected by DdeI
digestion of exon 14 of ATP2A2 in 50 British control
individuals, indicating that it is unlikely to be a neutral
polymorphism. No other change was detected in ATP2A2 in
the proband by CSGE.
Expression of P602L mutant Immunocytochemistry on
intact COS-1 cells (data not shown), and Western blotting of 10
mg of microsomal proteins (Fig 4a), isolated from COS-1 cells
overexpressing mutant P602L and wild-type SERCA2b
proteins, showed that the P602L mutant was expressed to a
nearly equal level as the wild-type. Figure 4(a) also
demonstrates the low expression level of the endogenous
SERCA2b protein in microsomes isolated from COS-1 cells
transfected with the empty vector only.
Ca2þ transport activity Oxalate-stimulated Ca2þ uptake was
measured in microsomes isolated from COS-1 cells transfected
with each of the following cDNAs: wild-type SERCA2b,
P602L mutant cDNA, and the expression vector without any
insert (Fig 4b). Upon transfection with the wild-type
SERCA2b, the determined Ca2þ uptake rate was 5.0 nmol
Ca2þ per mg microsomal protein per min, thus demonstrating
the ability of overexpressed Ca2þ ATPase to function as a Ca2þ
pump in the presence of ATP. In contrast, the mutant P602L,
which was expressed at a comparable level to the wild-type
protein (see Fig 4a), showed a Ca2þ uptake indistinguish-
able from that of microsomes isolated from COS-1 cells
transfected with the expression vector without insert. The
Ca2þ uptake values represent the average values of at least three
experiments.
DISCUSSION
Whether AKV and DD are separate entities or part of the same
disease process has been disputed for many years. The main argu-
ment in favor of AKV and DD being separate entities is the ex-
istence, as in this family, of pure pedigrees where members only
have features of AKV (Panja, 1977). Sampled lesions show no dys-
keratosis and there are no members with features of DD. In favor
Figure 3. Identi¢cation of ATP2A2 mutation. (a) CSGE showed
abnormal electrophoretic mobility of exon 14. Lanes 1^3: control 1, control
2, and the proband. (b) Direct sequencing of PCR products revealed a C to
T substitution at nucleotide position 1805, resulting in the proline to leu-
cine change at position 602 (P602L).
Figure 4. Functional analysis of P602L mutant. (a) Western blot
analysis. Microsomes overexpressing the indicated SERCA2 proteins were
immunostained with a SERCA2b-speci¢c polyclonal antibody (dilution
1 : 500). The 212 kDa band corresponds to SERCA2b dimers (Verboomen
et al, 1994). (b) Time dependence of Ca2+ transport. Ca2+ uptake rate for
wild-type SERCA2b is 5.0 nmoles Ca2+ per mg protein per min. Ca2+
uptake rate for P602L mutant is indistinguishable from that of the control
microsomes expressing endogenous SERCA2b protein.
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of AKV being part of the DD spectrum is the presence of mixed
pedigrees (Herndon andWilson, 1966) and it is notable that 50%
of Darier’s patients have acral warty papules (Penrod et al, 1960;
Waisman, 1960).There are reports of patients with AKVwho later
developed clinical features of DD ^ one case concerned one of
Hopf’s original patients! It has also been argued that Darier-type
histologic changes of mild dyskeratosis may be seen in some le-
sions of AKV (Waisman, 1960).
We have shown for the ¢rst time that AKV can arise from a
missense mutation in ATP2A2, encoding the SERCA2 pump,
which is also defective in generalized DD. This result indicates
that AKVand DD are allelic disorders. Our ¢nding also supports
the possibility that AKVand DD represent variable expression of
the same disease. In support of this hypothesis is the fact that the
two phenotypes share several features in common. Alternatively,
AKV and DD could be considered as two di¡erent diseases
caused by di¡erent mutations in the same gene, as inVohwinkel’s
and the keratitisichthyosisdeafness syndrome, which are
caused by di¡erent mutations in the same human connexin-26
gene GJB2 (Maestrini et al, 1999; Richard et al, 2002).
TheATP2A2 mutation we describe, P602L, predicts a noncon-
servative amino acid substitution in the ATP binding domain of
SERCA2. This amino acid is conserved amongst human SER-
CA1, SERCA2, and SERCA3 isoforms (Dode et al, 1996). The
functional analysis of this SERCA2b mutant showed a complete
loss of Ca2þ transport activity. The complete loss of Ca2þ trans-
port activity due to the block of phosphoenzyme intermediate
formation was demonstrated for the same mutation in the related
rabbit fast-twitch skeletal muscle SERCA1a isoform (Clarke et al,
1990). Taken together, these results provide strong evidence that
this mutation leads to loss of function of SERCA2, resulting in
impaired Ca2þ transport across the sarco(endo)plasmic reticulum
membrane.
To our knowledge, the nonconservative missense mutation in
this AKV family, P602L, has not been found in patients with DD.
The mechanism by which ATP2A2 mutation gives rise to AKV,
not classical DD, is not yet understood. It is possible that the vari-
able expression may be determined by the nature and location of
the mutation, which may have di¡erent e¡ects on the function of
the SERCA2 pump. It is also likely that modifying genes could
play a role in the phenotypic expression of AKV and DD.
In conclusion, we provide the ¢rst evidence that AKV and
Darier’s disease are allelic disorders with phenotypic expression
of di¡erent severities. This result also raises new questions on the
mechanisms causing acral expression of the disease.
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